Delivery Order SPE2DB24D2205-SPE2DB25FDXSH

Award Date 1/31/25
Potential Completion Date 2/3/25
Potential Value $23K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,230.33 firm fixed-price delivery order is for the medical product MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract has an ultimate completion date of December 17, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a $13,182.59 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract has an ultimate completion date of July 24, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to provide a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $5,440.49 firm-fixed-price contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a completion date of May 7, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. The $8,452.60 firm fixed price contract has an ultimate completion date of August 14, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,057.31, is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. The order has a firm fixed price and an ultimate completion date of January 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a $1,936.25 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,242,943 units of the pharmaceutical product MONOVISC 88 MG/4 ML SYRINGE 4ML, with an ultimate completion date of July 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of its broader role as an Indefinite Delivery Contract (IDC) holder with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract has a firm fixed price of $10,704.62 and a completion date of September 13, 2024. AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, is the prime contractor. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under a $999,999,999 Indefinite Delivery Contract (IDC) to supply MONOVISC 88 MG/4 ML SYRINGE 4ML medical products. The award has a ceiling value of $26,226.46 and an ultimate completion date of July 17, 2024. The contract is a firm fixed-price arrangement with no set-aside designation. Amerisourcebergen, through its extensive pharmaceutical and medical...
This is a delivery order under an Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The delivery order, valued at $23,663.05, is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML medical products. This contract is part of a larger $999,999,999 IDC held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $33,621.03, is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. The contract is a firm fixed-price, delivery order contract with a period of performance through January 13, 2025. There is no set-aside designation for this contract award....
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDXSH
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,529.38 firm fixed-price contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a completion date of February 3, 2025.

AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is issued under that IDC. The contract does not have a set-aside designation, indicating open competition.

Generated 5/2/25, 10:21 AM